Aurobindo Pharma Limited — Updates, 17-08-2026: General Updates
17-08-2026 | 07:34 am
17-08-2026 | 07:34 am
Aurobindo's Raleigh plant USFDA inspection is now classified as Voluntary Action Indicated (VAI), closing the case. This positive development means pending inhaler and other product applications from the facility can now advance.
No comments yet. Be the first to comment!
